Anavex Life Sciences Corp. (AVXL) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 132.99M | 103.81M | 101.16M | 117.14M | 124.04M | 135.57M | 141.53M | 144.52M | 148.07M | 154.39M | 157.81M | 159.19M |
| Cash & Short-Term Investments | 131.75M | 102.58M | 101.16M | 115.77M | 120.78M | 132.19M | 138.76M | 139.39M | 143.76M | 151.02M | 154.82M | 153.47M |
| Cash Only | 131.75M | 102.58M | 101.16M | 115.77M | 120.78M | 132.19M | 138.76M | 139.39M | 143.76M | 151.02M | 154.82M | 153.47M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 844K | 809K | 820K | 666K | 2.56M | 2.45M | 1.72M | 3.79M | 3.55M | 2.71M | 2.17M | 4.74M |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 396K | 429K | -820K | 702K | 711K | 931K | 1.06M | 1.34M | 756K | 653K | 827.57K | 981.77K |
| Total Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 234K | 0 | 3.36M | 0 | 0 |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 89K | 234K | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | -89K | 0 | 0 | 3.36M | 0 | 0 |
| Total Assets | 132.99M | 103.81M | 102.43M | 117.14M | 124.04M | 135.57M | 141.53M | 144.75M | 148.07M | 154.39M | 157.81M | 159.19M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 7.21% | -23.42% | -27.63% | -19.07% | -16.23% | -12.19% | -10.31% | -9.07% | -0.2% | 1.1% | -1.5% | -0.68% |
| Total Current Liabilities | 6.37M | 8.95M | 11.47M | 17.38M | 13.13M | 15.3M | 11.75M | 9.56M | 12.49M | 12.53M | 11.06M | 14.02M |
| Accounts Payable | 2.64M | 4.25M | 6.74M | 7M | 4.57M | 9.63M | 3.5M | 3.73M | 4.29M | 4.32M | 4.15M | 6.28M |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 805K | 805K | 805K | 829K | 829K | 842K | 917K | 917K | 917K | 917K | 916.76K | 916.76K |
| Other Current Liabilities | 1.7M | 1.56M | 1.19M | 2.2M | 2.02M | 1.53M | 1.03M | 0 | 0 | 0 | 916.76K | 1.57M |
| Current Ratio | 20.87x | 11.60x | 8.82x | 6.74x | 9.45x | 8.86x | 12.04x | 15.12x | 11.85x | 12.32x | 14.27x | 11.35x |
| Quick Ratio | 20.87x | 11.60x | 8.82x | 6.74x | 9.45x | 8.86x | 12.04x | 15.12x | 11.85x | 12.32x | 14.27x | 11.35x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 6.37M | 8.95M | 11.47M | 17.38M | 13.13M | 15.3M | 11.75M | 9.56M | 12.49M | 12.53M | 11.06M | 14.02M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Debt | -131.75M | -102.58M | -101.16M | -115.77M | -120.78M | -132.19M | -138.76M | -139.39M | -143.76M | -151.02M | -154.82M | -153.47M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | -12.54x |
| Total Equity | 126.62M | 94.87M | 90.96M | 99.76M | 110.92M | 120.26M | 129.78M | 135.19M | 135.57M | 141.85M | 146.75M | 145.17M |
| Equity Growth % | 14.16% | -21.12% | -29.91% | -26.21% | -18.19% | -15.22% | -11.57% | -6.87% | 0.33% | -0.45% | -2.64% | -4.63% |
| Book Value per Share | 1.42 | 1.10 | 1.07 | 1.17 | 1.31 | 1.43 | 1.54 | 1.64 | 1.65 | 1.78 | 1.81 | 1.85 |
| Total Shareholders' Equity | 126.62M | 94.87M | 90.96M | 99.76M | 110.92M | 120.26M | 129.78M | 135.19M | 135.57M | 141.85M | 146.75M | 145.17M |
| Common Stock | 93K | 87K | 85K | 85K | 85K | 85K | 85K | 84K | 82K | 82K | 81.39K | 80.24K |
| Retained Earnings | -388.13M | -382.45M | -372.62M | -359.38M | -348.18M | -336.07M | -324.45M | -312.24M | -301.69M | -293.07M | -282.92M | -271.64M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | -89K | -234K | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |